Back to Search Start Over

Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines:A Systematic Review

Authors :
Eric Bruckert
Børge G. Nordestgaard
Periklis Giovas
Klaus G. Parhofer
Kausik K. Ray
Jose Ramon Gonzalez-Juanatey
Marcello Arca
Service d’Endocrinologie, Métabolisme et Prévention des Risques Cardio-Vasculaires [CHU Pitié-Salpêtrière]
CHU Pitié-Salpêtrière [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Institut E3M [CHU Pitié-Salpêtrière]
Klinikum der Universitat Munchen
Ludwig-Maximilians-Universität München (LMU)
Universidade de Santiago de Compostela [Spain] (USC )
IT University of Copenhagen
Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome]
Imperial College London
Gestionnaire, Hal Sorbonne Université
Service d'Endocrinologie, Métabolisme et Prévention des Maladies Cardio-vasculaires [CHU Pitié-Salpêtrière]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
IT University of Copenhagen (ITU)
Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA)
Source :
Bruckert, E, Parhofer, K G, Gonzalez-Juanatey, J R, Nordestgaard, B, Arca, M, Giovas, P & Ray, K 2020, ' Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines : A Systematic Review ', Advances in Therapy, vol. 37, no. 5, pp. 1724-1736 . https://doi.org/10.1007/s12325-020-01285-2, Advances in Therapy, Advances in Therapy, Springer Verlag (Germany), 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩, Advances in Therapy, 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩
Publication Year :
2020

Abstract

Objective Assess achievement of low-density lipoprotein cholesterol (LDL-C) targets in European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines. Design Systematic literature review. Data Sources Medline, EMBASE, Cumulated Index to Nursing and Allied Health Literature. Eligibility Criteria Observational studies reporting LDL-C levels/target attainment, measured between 1 August 2006 to 31 August 2017, in European adults with established cardiovascular disease (CVD), diabetes with target organ damage, familial hypercholesterolaemia (FH) or 10-year risk of fatal CVD ≥ 5% (assessed by Systematic Coronary Risk Evaluation [SCORE]). Data Extraction and Synthesis Two reviewers independently extracted relevant studies and assessed study quality using the Risk of Bias for Non-Randomised Studies–Interventions (ROBINS-I) tool. Primary outcome was the proportion of patients achieving LDL-C targets in the 2011/2016 ESC/EAS guidelines. Where available, patient characteristics were presented as means weighted by sample size. The proportions of patients achieving LDL-C targets in the 5 years before and after publication of the 2011 guidelines were compared using a chi-square test. Results Across 81 eligible studies (303,534 patients), achievement of LDL-C

Details

Language :
English
ISSN :
0741238X
Database :
OpenAIRE
Journal :
Bruckert, E, Parhofer, K G, Gonzalez-Juanatey, J R, Nordestgaard, B, Arca, M, Giovas, P & Ray, K 2020, ' Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines : A Systematic Review ', Advances in Therapy, vol. 37, no. 5, pp. 1724-1736 . https://doi.org/10.1007/s12325-020-01285-2, Advances in Therapy, Advances in Therapy, Springer Verlag (Germany), 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩, Advances in Therapy, 2020, 37 (5), pp.1724-1736. ⟨10.1007/s12325-020-01285-2⟩
Accession number :
edsair.doi.dedup.....6fb35706845713d08a1f802628a57d3f